EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY 4.0

Clinical Outcomes of Transfemoral Transcatheter Mitral Valve Replacement

Lena Strotmann, Andrea Scotti, Augustin Coisne, Adrian Heinze, Lukas Stolz, Philipp von Stein, Walid Ben Ali, Camil Succar, Damiano Regazzoli, Mirjam Keßler, Alison Duncan, Tanja K Rudolph und 48 weitere

JACC: Cardiovascular Interventions · 2026

DOI: 10.1016/j.jcin.2026.05.003 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JACC: Cardiovascular Interventions, 2026. Verfasst von Lena Strotmann und 59 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University Heart and Vascular Center Hamburg, Hamburg, Germany; German Center for Cardiovascular Research, Partner Site Ham…. Hauptthemen laut MEDLINE: Mitral Valve Insufficiency, Transcatheter Mitral Valve Replacement, Mitral Valve, Femoral Artery. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Heart Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Transcatheter mitral valve replacement (TMVR) is an alternative for patients with mitral regurgitation (MR), but data on transfemoral (TF) devices are limited. OBJECTIVES: The aim of this study was to evaluate clinical, echocardiographic, and functional outcomes following TF TMVR in an international registry. METHODS: The CHOICE-MI (Choice of Optimal Transcatheter Treatment for Mitral Insufficiency) Registry included patients undergoing TMVR with dedicated devices at 41 international centers. This analysis included only TF TMVR. Outcomes were assessed per Mitral Valve Academic Research Consortium criteria. Echocardiographic, functional, and clinical outcomes up to 2 years were reported. The primary endpoint was a composite of all-cause mortality or heart failure hospitalization at 2 years. Predictors were identified using multivariable Cox regression. RESULTS: A total of 124 patients (median age 79 years [Q1-Q3: 75-83 years], 50% women, median European System for Cardiac Operative Risk Evaluation II score 5.0% [Q1-Q3: 3.3-8.5]) underwent TF TMVR with 9 different devices. The leading MR etiology was primary MR (n = 49 [39.5%]), with mitral annular calcification in 12.9%. Technical success was achieved in 113 of 124 patients (91.1%), and procedural mortality was low (1 of 124 [0.8%]). Residual MR ≤1+ was achieved in 94.9% at discharge, with stable results at follow-up. The rates of cardiovascular mortality were 14.7% (95% CI: 7.9%-21.5%) and 20.3% (95% CI: 11.4%-29.1%) and of the primary endpoint 44.1% (95% CI: 30.6%-50.0%) and 52.4% (95% CI: 40.2%-62.1%) at 1 and 2 years, respectively, and NYHA functional class had significantly improved at 1- and 2-year follow-up. Atrial fibrillation was an independent predictor of the primary endpoint, whereas technical success was associated with survival. CONCLUSIONS: TMVR using dedicated TF devices demonstrates favorable safety, durable MR reduction, and sustained functional improvement in high-risk patients. (Choice of Optimal Transcatheter Treatment for Mitral Insufficiency Registry [CHOICE-MI Registry]; NCT04688190).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mitral Valve InsufficiencyTranscatheter Mitral Valve ReplacementMitral ValveFemoral ArteryCatheterization, PeripheralCardiac CatheterizationHumansFemaleRegistriesAgedMaleTime FactorsRisk FactorsAged, 80 and overTreatment OutcomeRecovery of FunctionEuropeHeart Valve ProsthesisHeart FailureHemodynamics

Stichwörter der Autor:innen

mitral regurgitationtranscatheter mitral valve replacementtransfemoral

Autor:innen und Institutionen

  • Department of Cardiology, University Heart and Vascular Center Hamburg, Hamburg, Germany; German Center for Cardiovascular Research, Partner Site Hamburg/Kiel/Lübeck, Hamburg, Germany.
  • Cardiovascular Research Foundation, New York, New York, USA; Montefiore Medical Center, Montefiore-Einstein Center for Heart and Vascular Care, New York, New York, USA.
  • Cardiovascular Research Foundation, New York, New York, USA; Université de Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.
  • Department of Cardiology, University Heart and Vascular Center Hamburg, Hamburg, Germany.
  • Medizinische Klinik und Poliklinik I, Klinikum der Universität München, Munich, Germany.
  • Cardiovascular Research Foundation, New York, New York, USA; Department of Cardiology, Heart Center, University of Cologne, Cologne, Germany.

Förderung

  • German Heart Foundation

Zitieren

APA

Strotmann, L., Scotti, A., Coisne, A., Heinze, A., Stolz, L., von Stein, P., Ben Ali, W., Succar, C., Regazzoli, D., Keßler, M., Duncan, A., Rudolph, T. K., Heide, I. V., Schulz, C., Köll, B., Kalbacher, D., Schofer, N., Nickenig, G., Ruge, H., …, & Ludwig, S. (2026). Clinical Outcomes of Transfemoral Transcatheter Mitral Valve Replacement. JACC: Cardiovascular Interventions. https://doi.org/10.1016/j.jcin.2026.05.003

Vancouver

Strotmann L, Scotti A, Coisne A, Heinze A, Stolz L, von Stein P, et al. Clinical Outcomes of Transfemoral Transcatheter Mitral Valve Replacement. JACC: Cardiovascular Interventions. 2026. doi:10.1016/j.jcin.2026.05.003

BibTeX
@article{Strotmann2026,
  author = {Strotmann, Lena and Scotti, Andrea and Coisne, Augustin and Heinze, Adrian and Stolz, Lukas and von Stein, Philipp and Ben Ali, Walid and Succar, Camil and Regazzoli, Damiano and Keßler, Mirjam and Duncan, Alison and Rudolph, Tanja K and Heide, Ina von der and Schulz, Carl and Köll, Benedikt and Kalbacher, Daniel and Schofer, Niklas and Nickenig, Georg and Ruge, Hendrik and Adam, Matti and Giannini, Cristina and de Backer, Ole and Adamo, Marianna and Garatti, Andrea and Frerker, Christian and Stiermaier, Thomas and Dahle, Gry and Taramasso, Maurizio and Walther, Thomas and Kempfert, Joerg and Dumonteil, Nicolas and Obadia, Jean-François and Tahirkheli, Naeem and Grygier, Marek and Généreux, Philippe and Bezerra, Hiram G and Wróbel, Krzysztof and Waggoner, Thomas E and Andreas, Martin and Redwood, Simon and Tang, Gilbert H L and Reardon, Michael and Sorajja, Paul and Fam, Neil and Muller, David W and Praz, Fabien and von Bardeleben, Ralph Stephan and Hausleiter, Jörg and Mangieri, Antonio and Ninios, Vlasis and Denti, Paolo and Rottbauer, Wolfgang and Webb, John G and Blankenberg, Stefan and Rodés-Cabau, Josep and Latib, Azeem and Granada, Juan F and Conradi, Lenard and Modine, Thomas and Ludwig, Sebastian},
  title = {Clinical Outcomes of Transfemoral Transcatheter Mitral Valve Replacement},
  journal = {JACC: Cardiovascular Interventions},
  year = {2026},
  doi = {10.1016/j.jcin.2026.05.003}
}
Kostenlos starten →